UltraShape Secures $15.1 Million in New Financing Led by Meritech Capital

    PALO ALTO, CALIF. & YOKNEAM, ISRAEL, September 5 /CNW/ - UltraShape, a
global leader in non-invasive body contouring, today announced it has
completed a $15.1 million round of funding. The financing was led by new
investor Meritech Capital Partners, with participation from both of its
previous institutional investors, Israel Seed Partners and Polaris Venture

    "Our style of investing targets late-stage companies that are best in
class," said Rob Ward, a founder and managing director at Meritech. "We have
been very impressed by UltraShape's technology, its ability to penetrate
global markets and its management team, and are very confident that UltraShape
will maintain its leadership position in the field of non-invasive body
contouring solutions."

    "We are very pleased to have Meritech join the UltraShape team," said
Rodger Stewart, UltraShape President and CEO. "The infusion of capital will
enable UltraShape to accelerate global market adoption to meet the growing
demands for our body contouring solution. We are confident that Meritech's
experience and expertise will contribute significantly as UltraShape grows to
become a global leader in the aesthetics industry."

    About UltraShape

    UltraShape is redefining aesthetic medicine by developing, manufacturing
and marketing innovative non-invasive technologies for body contouring. The
company is dedicated to providing clinically proven safe and effective
solutions that enhance the lives of patients worldwide. The UltraShape
proprietary non-invasive body contouring technology is based on focused
ultrasound that targets and selectively disrupts fat cells without affecting
surrounding structures. Founded in 2000, UltraShape is a privately held and
venture backed company with offices in the United States, Israel, France,
United Kingdom, and Italy. The UltraShape system is not cleared by the FDA for
marketing in the United States. For more information visit www.ultrashape.com.

    About Meritech Capital Partners

    Meritech Capital Partners is a leading provider of late-stage venture
capital to the most promising private technology companies. With over $2.2
billion under management, Meritech seeks to lead investments in the portfolio
companies of leading early-stage venture capital firms and looks for companies
with proven and differentiated technology, rapidly-growing revenue and
seasoned management teams. As one of the most active late-stage investors,
Meritech provides guidance on a number of issues that rapidly growing
companies typically face, including management incentive plans, IPO market
timing and positioning, adviser selection, and post-IPO ownership transition.
Meritech is located in Palo Alto, CA and can be found at

For further information:

For further information: UltraShape Abigail Marks, +972-4-909-9260
abigail@ultrashape.com or FischerHealth Paula Moggio, 310-577-7870, x151
pmoggio@fischerhealth.com or Gitam Porter Novelli Jessica Fishman,
+972-3-576-5798 jessica@gitam.co.il

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890